Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Microdot Universal lancets 1.8mm/26gauge
21010900839
|
Microdot Universal lancets 1.8mm/26gauge | Other Appliances | Appliances | No data available |
|
Micronor HRT 1mg tablets
0604012P0BEAAAD
|
Micronor HRT | Norethisterone | Endocrine System | No data available |
|
MicroPeak peak flow meter standard range
21120000108
|
MicroPeak peak flow meter standard range | Peak Flow Meters | Appliances | No data available |
|
Microval 30microgram tablets
0703021L0BBAAAA
|
Microval | Levonorgestrel | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Mictral granules 7g sachets
0501120N0BDAAAC
|
Mictral | Nalidixic acid | Infections | No data available |
|
Midazolam 100mg/50ml solution for infusion vials
1501041T0AAARAR
|
Midazolam hydrochloride | Midazolam hydrochloride | Anaesthesia | No data available |
|
Midazolam 11mg/5ml oral liquid
0408020V0AAAMAM
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | No data available |
|
Midazolam 15mg tablets
0408020V0AAABAB
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | No data available |
|
Midazolam 2.5mg/0.25ml oromucosal soln pf oral syringes
0408020W0AAAGAG
|
Midazolam hydrochloride (Buccal) | Midazolam hydrochloride | Central Nervous System | No data available |
|
Midazolam 2.5mg/5ml oral liquid
0408020V0AAAGAG
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | No data available |
|
Midazolam 20mg/5ml oral liquid
0408020V0AAAJAJ
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | No data available |
|
Midazolam 2mg/ml oral solution sugar free
0408020W0AAAHAH
|
Midazolam hydrochloride (Buccal) | Midazolam hydrochloride | Central Nervous System | No data available |
|
Midazolam 40mg/5ml oral liquid
0408020V0AAAKAK
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | No data available |
|
Midazolam 6.25mg/5ml oral liquid
0408020V0AAAIAI
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | No data available |
|
Midazolam 7.5mg tablets
0408020V0AAACAC
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | No data available |
|
Midazolam 7.5mg/0.75ml oromucosal soln pf oral syringes
0408020V0AAAUAU
|
Midazolam maleate (Buccal) | Midazolam maleate | Central Nervous System | No data available |
|
Midetorin 2.5mg/5ml oral solution (Actavis)
0304010ABBDAAAD
|
Midetorin | Desloratadine | Respiratory System | No data available |
|
Midetorin 2.5mg/5ml oral solution (Arrow)
0304010ABBDABAD
|
Midetorin | Desloratadine | Respiratory System | No data available |
|
Midomil 1mg/5ml solution for infusion vials
0207020AABBAAAA
|
Midomil | Isoprenaline hydrochloride | Cardiovascular System | No data available |
|
Midostaurin 25mg capsules
0801050CKAAAAAA
|
Midostaurin | Midostaurin | Malignant Disease and Immunosuppression | No data available |
|
Midotense 2.5mg tablets
0207020Y0BEAAAE
|
Midotense | Midodrine hydrochloride | Cardiovascular System | No data available |
|
Mifegyne 200mg tablets
0701020K0BBAAAA
|
Mifegyne | Mifepristone | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Mifepristone 200mg tab and Misoprostol 200microg vaginal tab
0701021A0AAAAAA
|
Mifepristone/misoprostol | Mifepristone/misoprostol | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Mifepristone 200mg tablets
0701020K0AAAAAA
|
Mifepristone | Mifepristone | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Migalastat 123mg capsules
0908010AQAAAAAA
|
Migalastat | Migalastat | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.